1. Institute of Biomedical Chemistry, Moscow, Russia 2. Hertsen Moscow Oncology Research Center – branch of National Medical Research Radiological Center of the Ministry of Health, Moscow, Russia 3. Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Science, Moscow, Russia
Using flow cytometry GD2 ganglioside expression was evaluated both on colorectal adenocarcinoma cell lines and on tumor tissue samples from colorectal cancer patients. The marker was found on EpCAM-positive tumor cells in 6 of 12 patients' samples but not on the HT29 and CaCo-2 cell lines. GD2 expression was not an exceptional feature of cancer stem cells, since its expression level was similar on CD133-positive and CD133-negative tumor cells. Thus, the presence of GD2 ganglioside was revealed on colorectal adenocarcinoma cells for the first time. This finding makes it possible to use targeted therapy to treat this disease.
Lupatov A.Yu. et al. Expression of ganglioside GD2 on colorectal adenocarcinoma cells // Biomeditsinskaya khimiya. - 2020. - V. 66. -N 1. - P. 95-99.
Lupatov A.Yu. et al., "Expression of ganglioside GD2 on colorectal adenocarcinoma cells." Biomeditsinskaya khimiya 66.1 (2020): 95-99.
Lupatov, A. Yu., Gisina, A. M., Kim, Y. S., Bykasov, S. A., Volchenko, N. N., Sidorov, D. V., Yarygin, K. N., Kholodenko, R. V. (2020). Expression of ganglioside GD2 on colorectal adenocarcinoma cells. Biomeditsinskaya khimiya, 66(1), 95-99.
Battula V.L., Shi Y., Evans K.W., Wang R.Y., Spaeth E.L., Jacamo R.O., Guerra R., Sahin A.A., Marini F.C., Hortobagyi G., Mani S.A., Andreeff M. (2012) J. Clin. Invest, 122(6), 2066-2278. CrossRef Scholar google search